Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SGN-40 plus R-ICE versus placebo plus R-ICE in second-line diffuse large B-cell lymphoma
2007-002917-38Phase 2Completed
- Sponsor
- Seagen Inc.
- Start
- Sep 2007
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, randomised trial in diffuse large B-cell lymphoma (DLBCL) comparing SGN-40 + R-ICE with Placebo + R-ICE (2 arms). Primary endpoint: Complete response. Started Sep 2007; status: completed.
02
Drugs
dacetuzumab
03
Conditions
diffuse large B-cell lymphoma (DLBCL)
Beyond the preview
Go deeper on 2007-002917-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002917-38.